Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Khiron Life Sciences Corp V.KHRN.H

Alternate Symbol(s):  V.KHRN.WT.H | KHRNF | KHRWF

Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line, the Company is focused on product sales in Latin America. The Company operates its own network of health centers (operating under the Zerenia brand) and Zerenia satellite clinics offering a suite of health, medical and surgical services, in alignment with both insurance company partners and private practice. Its subsidiaries include Khiron Life Sciences Corp. (Canada), Khiron Colombia S.A.S., Zerenia S.A.S., NettaGrowth International Inc., and others.


TSXV:KHRN.H - Post by User

Bullboard Posts
Comment by Benedictuson Nov 15, 2019 2:21am
92 Views
Post# 30354637

RE:RE:RE:RE:RE:RE:Ted Ohashi Interview with Alvaro- part 1

RE:RE:RE:RE:RE:RE:Ted Ohashi Interview with Alvaro- part 1agreed there is a lot of marketing and kickback marketing in the mj game. But as I said I'll take Ohashi at his word that he is not paid to distribute his weekly views on the sector. As you have no evidence that he is being paid to interview Alvarro, I'll let that stand as the main point I was making. 

Now that canopy earnings have tanked the sector even further, it is an absolute free for all of throwing the baby out with the bathwater. Valuations on some US mj companies are getting absolutely ridiculous, some even falling to a current price to sales ratio of 1, while many of the big canadian LPs still have psr's of 20, 30 or above. So, unfortunately, I agree there is the possibility that the khrn sp could fall further although your arbitrary target low keeps changing, it seems to have gone from .20 or .30 to .70 and now .40 or .50.  Seems silly that I even take you seriously enough to respond doesn't it?
Bullboard Posts